DavidLeonardAndolinoMD

Breast Cancer, Head & Neck, Urologic Cancer

Attending Physician

Dr. Andolino is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Icahn School of Medicine at Mount SinaiResidency, Radiation Oncology, 2011 - 2012
Indiana University School of MedicineResidency, Radiation Oncology, 2008 - 2011
George Washington UniversityInternship, Internal Medicine, 2007 - 2008
Rutgers New Jersey Medical SchoolClass of 2007

CMS Meaningful Use Stage 1 Certification ARIA Radiation Oncology EMR, Varian Medical Systems, 2013

PubMed

308 citations
Stereotactic body radiotherapy for primary hepatocellular carcinoma.
David L. Andolino, Cynthia S. Johnson, Mary A. Maluccio, Paul Y. Kwo, A. Joseph Tector
International Journal of Radiation Oncology, Biology, Physics. 2011-11-15
78 citations
Chest Wall Toxicity After Stereotactic Body Radiotherapy for Malignant Lesions of the Lung and Liver
David L. Andolino, Jeffrey A. Forquer, Mark A. Henderson, R.B. Barriger, Ronald H. Shapiro
International Journal of Radiation Oncology, Biology, Physics. 2011-07-01
186 citations
A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy.
R. Bryan Barriger, Jeffrey A. Forquer, Jeffrey G. Brabham, David L. Andolino, Ronald H. Shapiro
International Journal of Radiation Oncology, Biology, Physics. 2009-11-01